IL6 and diabetes mellitus: Since its identification in 1986 by molecular cloning of B-cell stimulatory factor-2 [71], IL-6 has been recognized as a cytokine with various biological activities implicated with a detrimental role in a wide range of inflammation-associated disease states, including susceptibility to diabetes mellitus [72].